# US Unnatural Amino Acids Market > US Unnatural Amino Acids Market Research Report: By Type (D-Amino Acids & Derivatives, DL-Amino Acids & Derivatives, B-Amino Acids & Derivatives, Cyclic Amino Acids & Derivatives, L-Amino Acid Derivatives, Gamma-Amino Butyric Acid, Gamma-Amino-Beta-Hydroxybutyric Acid, Synthetic-Amino Acids, Others), By Application (Liver Diseases, Cancer, Inflammatory Disease, Genetic Diseases) and By End User (Pharmaceutical & Biotechnological, Companies, Research Laboratories) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 0.4% - **2024:** $ 633 Million - **2025:** $ 630.47 Million - **2035:** $ 605.69 Million - **Key Players:** Ajinomoto Co Inc (JP), Evonik Industries AG (DE), Fufeng Group Ltd (CN), Kyowa Hakko Bio Co Ltd (JP), Nutraceutical International Corp (US), SAB Biotherapeutics Inc (US), Shaanxi Sciphar Hi-Tech Industry Co Ltd (CN), Sino Lion (CN) **Report ID:** MRFR/Pharma/12138-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-unnatural-amino-acids-market-13663 --- ## Market Summary ## **US Unnatural Amino Acids Market Overview** **As per MRFR analysis, the US Unnatural Amino Acids Market Size was estimated at 532 (USD Million) in 2023. The US Unnatural Amino Acids Market Industry is expected to grow from 588(USD Million) in 2024 to 1,491 (USD Million) by 2035. The US Unnatural Amino Acids Market CAGR (growth rate) is expected to be around 8.827% during the forecast period (2025 - 2035).** ### **Key US Unnatural Amino Acids Market Trends Highlighted** The US Unnatural Amino Acids Market has been experiencing significant growth driven by several key market drivers. The increasing demand for specialized food products, particularly in the dietary supplements and pharmaceutical sectors, is pushing the development of new formulations that incorporate these amino acids. Additionally, the rising awareness of health and wellness among consumers in the US is leading to a growing preference for products rich in unnatural amino acids that can enhance physical performance and improve mental health. Regulatory support from the FDA for certain types of [unnatural amino acids](../../../reports/unnatural-amino-acids-market-4909) in food and dietary supplements has also contributed positively to market stability. In recent times, trends show an intensified focus on research and development activities aimed at discovering novel applications for unnatural amino acids, particularly in functional foods. Furthermore, there is a growing interest among manufacturers in creating vegan and cruelty-free alternatives to traditional amino acid sources, catering to the rising plant-based consumer demographic in the US. This shift reflects broader lifestyle changes and sustainable practices becoming ingrained in American consumer culture. There are numerous opportunities to be explored within the US Unnatural Amino Acids Market. For example, partnerships between biotech firms and academic institutions can fuel innovative product development. Additionally, leveraging advancements in technology to enhance the bioavailability of unnatural amino acids may present a competitive edge. Companies can also capture the growing segment of health-conscious consumers looking for personalized nutrition solutions tailored to their specific dietary needs and preferences. This adaptability to consumer trends will play a crucial role in shaping the future landscape of the market in the US. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Unnatural Amino Acids Market Drivers** ### **Increasing Demand in Pharmaceuticals and Biotechnology** The US Unnatural Amino Acids Market Industry is witnessing significant growth driven by the increasing demand for unnatural amino acids in pharmaceuticals and biotechnology. Unnatural amino acids are crucial for the development of advanced therapies and drugs, particularly in the areas of cancer treatment and genetic disorders. According to the National Institutes of Health, investment in biotechnology research and development has surged, reaching approximately 45 billion USD in the US in 2021, which is expected to continue fueling the demand for unnatural amino acids in drug synthesis and formulations. The presence of established pharmaceutical companies such as Pfizer and Merck, which are actively engaging in Research and Development (R&D) to create innovative therapeutics, further drives the need for unnatural amino acids, thereby propelling market growth. ### **Rising Applications in Nutritional Supplements** The growing trend towards health and wellness has led to a notable increase in the use of unnatural amino acids in nutritional supplements. According to the Council for Responsible Nutrition, approximately 77% of American adults use dietary supplements, with the demand for high-quality amino acid supplements rising substantially. This trend is supported by the Food and Drug Administration's initiatives to promote healthier dietary practices and lifestyle changes, encouraging a fortified nutrition regimen. Companies like Herbalife and Optimum Nutrition are significantly investing in product development incorporating unnatural amino acids, which are known for their potential benefits in muscle recovery and overall health, contributing to an increase in the US Unnatural Amino Acids Market. ### **Growing Interest in Personalized Nutrition** Personalized nutrition is becoming a key focus area for consumers in the US, as there is an increasing emphasis on tailored diets that fit individual health needs and goals. The American Dietetic Association reports that approximately 60% of consumers show interest in personalized products that cater to their specific dietary needs. Unnatural amino acids have been found to play a vital role in personalized nutrition, enhancing the bioavailability of nutrients and optimizing metabolic functions. Companies involved in the personalized nutrition space, including Nutrigenomix and DNAfit, are developing products that utilize unnatural amino acids to cater to consumer preferences, thereby advancing growth in the US Unnatural Amino Acids Market. ### **Technological Advancements in Production Methods** Technological innovations in the production methods of unnatural amino acids are driving growth in the US Unnatural Amino Acids Market Industry. Advances in synthesis techniques, such as enzymatic synthesis and biotechnological processes, are improving yield and reducing costs. The US Department of Agriculture reports a significant increase in funding for agricultural biotechnology, reaching about 6 billion USD in the last five years. This funding supports the development of more efficient production methods for unnatural amino acids, enabling companies to meet the rising market demand. Firms like Evonik and Ajinomoto are at the forefront of implementing these advanced production technologies, which will enhance accessibility and affordability of unnatural amino acids in the market. ## **US Unnatural Amino Acids Market Segment Insights** ### **Unnatural Amino Acids Market Type Insights** The US Unnatural Amino Acids Market is characterized by a diverse array of types, each playing a crucial role in various applications across industries, particularly in pharmaceuticals, food, and feed. Among these types, D-Amino Acids and derivatives are gaining attention due to their potential therapeutic applications, particularly in neurology and psychiatry. This segment has shown growth as the understanding of their importance in neurotransmission and their role in disease management expands. DL-Amino Acids and derivatives are similarly important due to their fundamental role in protein synthesis and increasing utilization in dietary supplements. The B-Amino Acids and derivatives segment is notable for its emerging applications in agrochemicals and pharmaceuticals, showcasing versatility and growth potential. Cyclic Amino Acids and derivatives stand out for their stability and efficacy in drug formulations, presenting opportunities for innovative therapeutic solutions. L-Amino Acid Derivatives dominate the market due to their widespread use and demand in biochemistry and biotechnology applications, particularly for their functionalities in peptide synthesis. Additionally, Gamma-Amino Butyric Acid is notable for its potential health benefits, including anxiety reduction, contributing to its growing presence in the nutritional supplements sector. Gamma-Amino-Beta-Hydroxybutyric Acid is witnessing an increase in interest for its applications in both neuroscience and bodybuilding, thus creating a niche yet significant market segment. Synthetic-Amino Acids are pivotal due to their tailored properties and broad utility in research and industrial applications, thereby holding a majority share of this market. Furthermore, the category labeled 'Others' encompasses a range of unique formulations that cater to specialized needs, enhancing the overall diversity and adaptability of the market. The US Unnatural Amino Acids Market segmentation showcases a landscape that is driven by the need for innovative solutions across various sectors while capitalizing on the growing awareness concerning health and wellness, supported by better research and development initiatives. Rising consumer health consciousness and advances in biotechnology also present significant opportunities for each of these types, underscoring the substantial growth trajectory anticipated in the coming years. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Unnatural Amino Acids Market Application Insights** The Application segment of the US Unnatural Amino Acids Market focuses on critical areas such as liver diseases, cancer, inflammatory diseases, and genetic diseases, each playing a vital role in healthcare applications. The prevalence of liver diseases, driven by factors like alcohol consumption and obesity, necessitates targeted therapies that utilize unnatural amino acids for treatment effectiveness. Cancer treatment is increasingly incorporating these compounds due to their potential in personalized medicine, enhancing the efficacy of chemotherapy and reducing side effects. Inflammatory diseases, which impact millions of Americans, have seen advancements through unnatural amino acids that modulate immune responses and promote healing. Genetic diseases also represent a significant application for unnatural amino acids, as they enable tailored therapeutic solutions for rare conditions. The rising demand for innovative treatment methodologies, coupled with ongoing research and development in these areas, drives the evolution of the US Unnatural Amino Acids Market, reflecting a growth trajectory aligned with emerging healthcare needs. As researchers discover new applications and benefits, the utilization of unnatural amino acids continues to expand, addressing both prevalent and complex health issues in the United States. ### **Unnatural Amino Acids Market End User Insights** The US Unnatural Amino Acids Market is significantly driven by diverse end users, primarily comprising Pharmaceutical and Biotechnological companies, Research Laboratories, and other entities engaged in scientific advancements. The pharmaceutical industry employs unnatural amino acids for the development of innovative drugs and therapies, enhancing efficacy and safety profiles. The growing focus on personalized medicine and targeted therapies is a major impetus in this domain. In contrast, Research Laboratories play a crucial role in studying and developing new applications and research methodologies involving unnatural amino acids, aiding in scientific discoveries. This segment is characterized by a noteworthy interest in peptide synthesis, protein engineering, and metabolic studies. Furthermore, there is a sharp rise in collaborations between biopharmaceutical companies and research institutions, fostering innovation and efficiency within the industry. The importance of these segments within the broader landscape is underscored by their contribution to advancements in healthcare and the biotechnology field, fueling significant progress in treatment options and scientific understanding. The US stands as a leader in amino acid research and application, with various institutions and companies significantly impacting both domestic and global markets in this sector. ## **US Unnatural Amino Acids Market Key Players and Competitive Insights** The US Unnatural Amino Acids Market reflects a complex landscape driven by increasing applications in biotechnology, pharmaceuticals, and nutraceuticals. As the demand for innovative therapeutics and research tools escalates, the competition among key players in this sector intensifies. Various companies are expanding their product portfolios, enhancing their manufacturing capabilities, and refining their distribution networks to gain a stronger market foothold. The growing focus on personalized medicine and advancements in synthetic biology further fuel the competitive dynamics of this market. This environment encourages continuous innovation while challenging companies to maintain quality and compliance with regulatory standards. Firms are also leveraging strategic partnerships and collaborations to enhance their market share and adapt to emerging trends. Tocris Bioscience has established a notable presence in the US Unnatural Amino Acids Market by focusing on the development and supply of high-quality research tools for scientists. The company excels in providing a wide range of product offerings, specifically tailored to cater to the diverse needs of the research community. Tocris Bioscience is recognized for its commitment to innovation and quality, which strengthens its brand reputation among researchers. Their strategic focus on customer support and educational resources allows them to build strong relationships within the scientific community. The company’s emphasis on expanding its product lines and improving customer engagement positions it advantageously within the competitive landscape of the US market for unnatural amino acids. Cayman Chemical is a significant player in the US Unnatural Amino Acids Market, recognized for its comprehensive range of products catering to various research and development activities. The company specializes in the production of high-purity unnatural amino acids that serve critical roles in biochemical research and therapeutic applications. Cayman Chemical's strengths lie in its robust research and development capabilities, leading to continuous innovation in product offerings. The company also emphasizes quality and compliance with regulatory guidelines, ensuring that its products meet strict scientific standards. Cayman Chemical has engaged in strategic mergers and acquisitions, enabling it to broaden its market presence and enhance its product portfolio. With a focus on customer satisfaction and expanding distribution channels, Cayman Chemical remains a competitive force in the US market for unnatural amino acids. ### **Key Companies in the US Unnatural Amino Acids Market Include** ## **US Unnatural Amino Acids Market Industry Developments** Recent news developments in the US Unnatural Amino Acids Market indicate an increased focus on innovation and collaboration among key players such as Tocris Bioscience, Cayman Chemical, and New England Biolabs. The market has seen significant growth, with notable advancements in applications ranging from pharmaceuticals to agricultural biotechnology, which has highlighted the importance of these compounds in various industry sectors. In July 2023, Evonik Industries announced a partnership with Kyowa Hakko Bio to enhance their production capabilities for amino acid derivatives, reflecting the ongoing consolidation trend in the market. Furthermore, Thermo Fisher Scientific and GenScript have expanded their product portfolios through strategic investments, contributing to a more competitive landscape. On the financial side, companies like Bachem and Ajinomoto reported increased valuations and revenue growth driven by rising demand, which is positively impacting the overall market dynamics. The last couple of years have seen accelerated R&D efforts, particularly in the context of personalized medicine and biopharmaceutical development, reinforcing the critical role of unnatural amino acids in advancing scientific research and commercial applications in the US. ## **US Unnatural Amino Acids Market Segmentation Insights** ### **Unnatural Amino Acids Market Type Outlook** ### **Unnatural Amino Acids Market Application Outlook** ### **Unnatural Amino Acids Market End User Outlook** - Pharmaceutical & Biotechnological Companies - Research Laboratories ## Market Drivers ### Advancements in Biotechnology Technological advancements in biotechnology are significantly influencing the unnatural amino-acids market. Innovations in genetic engineering and synthetic biology have enabled the production of unnatural amino acids with enhanced properties and functionalities. These advancements allow for more efficient and cost-effective production processes, which can potentially lower prices and increase accessibility. The biotechnology sector is projected to grow at a CAGR of around 7% through 2027, suggesting a favorable environment for the unnatural amino-acids market. As companies leverage these technologies, the market is expected to expand, driven by the introduction of novel products and applications. ### Rising Demand in Food Industry The food industry is increasingly recognizing the potential of unnatural amino acids, contributing to the growth of the unnatural amino-acids market. These compounds are utilized as flavor enhancers, preservatives, and nutritional supplements in various food products. The unnatural amino-acids market is projected to reach $50 billion by 2026, with a significant share attributed to amino acids. As consumers demand healthier and more functional food options, manufacturers are likely to incorporate unnatural amino acids to meet these needs. This trend indicates a growing acceptance and application of these compounds in food production, further driving market growth. ### Increasing Applications in Pharmaceuticals The unnatural amino-acids market is experiencing growth due to their increasing applications in the pharmaceutical sector. These amino acids are utilized in drug formulation, particularly in the development of novel therapeutics. For instance, they are essential in synthesizing peptide-based drugs, which have shown efficacy in treating various diseases. The market for peptide therapeutics is projected to reach approximately $50 billion by 2026, indicating a robust demand for unnatural amino acids. Furthermore, the rise in chronic diseases necessitates innovative drug solutions, further driving the need for these compounds. As pharmaceutical companies continue to invest in research and development, the unnatural amino-acids market is likely to benefit significantly from this trend. ### Emerging Research in Therapeutic Applications Ongoing research into the therapeutic applications of unnatural amino acids is a key driver for the market. Studies are exploring their potential in treating conditions such as cancer, metabolic disorders, and neurodegenerative diseases. The increasing focus on personalized medicine and targeted therapies is likely to enhance the demand for these amino acids, as they can be tailored to specific therapeutic needs. The research and development expenditure in the US healthcare sector is expected to exceed $200 billion by 2026, indicating a strong commitment to innovation. This investment is likely to foster advancements in the unnatural amino-acids market, as new applications and formulations are developed. ### Growth in Nutraceuticals and Dietary Supplements The rising health consciousness among consumers is propelling the growth of the unnatural amino-acids market, particularly in the nutraceuticals and dietary supplements sector. Unnatural amino acids are increasingly incorporated into supplements aimed at enhancing athletic performance, muscle recovery, and overall health. The dietary supplement market in the US is expected to surpass $50 billion by 2025, with a notable portion attributed to amino acid-based products. This trend is driven by the growing preference for natural and functional foods, as consumers seek products that offer health benefits. Consequently, the demand for unnatural amino acids is likely to rise as manufacturers innovate to meet consumer expectations. ## Future Outlook The [Unnatural Amino Acids Market](https://www.marketresearchfuture.com/reports/unnatural-amino-acids-market-4909) is projected to experience a decline of -0.4% CAGR from 2025 to 2035, driven by evolving consumer preferences and regulatory changes. **New opportunities:** - Development of customized amino-acid blends for niche dietary supplements. Expansion into emerging markets with tailored marketing strategies. Investment in R&D for innovative applications in pharmaceuticals. By 2035, the market is expected to stabilize, adapting to new consumer demands and regulatory landscapes. ## Segment Insights ### By Type: L-Amino Acid Derivatives (Largest) vs. D-Amino Acids & Derivatives (Fastest-Growing) The US unnatural amino-acids market is experiencing a dynamic distribution among various segment values. L-Amino Acid Derivatives hold the largest share due to their extensive use in pharmaceuticals and food applications. Following closely, D-Amino Acids & Derivatives have emerged as significant contributors, propelled by their increasing demand in nutraceuticals and dietary supplements. Other segments like Gamma-Amino Butyric Acid (GABA) and Synthetic-Amino Acids also contribute to the market but at a comparatively lower rate. Growth trends within this segment are largely driven by increasing health awareness and a rising inclination towards plant-based protein sources among consumers. The demand for D-Amino Acids & Derivatives is notably on the rise due to their unique functional properties, appealing to innovative product developers. Meanwhile, L-Amino Acid Derivatives maintain their dominance owing to their versatile applications. This healthy competitive environment fosters continual advancements and expansions in the market, ensuring sustained growth in this dynamic landscape. L-Amino Acid Derivatives (Dominant) vs. D-Amino Acids & Derivatives (Emerging) L-Amino Acid Derivatives are recognized for their prevalence in the pharmaceutical sector, serving as critical intermediates in drug formulation and offering therapeutic benefits. Their comprehensive applications across various industries, coupled with a robust supply chain, position them as the dominant force in the market. On the other hand, D-Amino Acids & Derivatives have gained traction as an emerging segment, favored for their bioactive properties and roles in enhancing cognitive function and metabolic health. As research continues to unveil their benefits, this segment is rapidly adapting to increasing consumer expectations, thereby presenting significant growth potential within the US unnatural amino-acids market. ### By Application: Liver Diseases (Largest) vs. Cancer (Fastest-Growing) In the US unnatural amino-acids market, the application segment reveals that Liver Diseases dominate the market share, driven by the increasing prevalence of liver disorders and the rising demand for effective therapeutic solutions. Following closely, Cancer emerges as a significant application area, due to rising incidences and the ongoing research initiatives aimed at developing amino-acid-based treatments that can enhance the efficacy of existing cancer therapies. Growth trends within the application segment are largely influenced by the rising awareness regarding the potential benefits of amino acids in treating specific diseases. Liver Diseases are supported by a stable patient population and consistent treatment protocols, whereas Cancer is witnessing a rapid upward trajectory, thanks to advancements in medical research and a shift toward personalized medicine approaches that incorporate amino acids in treatment regimens. Liver Diseases: Dominant vs. Cancer: Emerging Liver Diseases represent a dominant application in the US unnatural amino-acids market, characterized by a well-established treatment landscape and a high demand for novel therapeutic options. This segment includes a wide range of conditions such as liver cirrhosis and non-alcoholic fatty liver disease, which require targeted treatment strategies that amino acids can provide. Conversely, Cancer is an emerging application segment, leveraging the latest technologies in biotechnology and pharmacology. With ongoing research and clinical trials, amino acids are being explored for their potential in strengthening cancer therapies, positioning this segment as a critical focus for future innovations. The contrast between the established protocols in treating Liver Diseases and the rapidly evolving landscape for Cancer highlights the dynamic nature of this market. ### By End-User: Pharmaceutical & Biotechnological Companies (Largest) vs. Research Laboratories (Fastest-Growing) In the US unnatural amino-acids market, Pharmaceutical & Biotechnological Companies dominate the end-user segment, accounting for a significant share. These organizations utilize unnatural amino acids extensively for drug development and therapeutic applications, leading to their substantial market presence. Research Laboratories, while smaller in market share, are emerging as a critical segment due to increased funding for scientific research and innovations. The growth trends within this segment demonstrate a rising demand driven by advancements in biotechnology and an increased focus on personalized medicine. Pharmaceutical & Biotechnological Companies continue to invest in R&D to enhance product offerings, while Research Laboratories capitalize on this trend by exploring novel applications. This dynamic interplay fosters an environment of innovation and drives the overall growth of the US unnatural amino-acids market. Pharmaceutical & Biotechnological Companies (Dominant) vs. Research Laboratories (Emerging) Pharmaceutical & Biotechnological Companies represent the dominant force in the US unnatural amino-acids market, benefiting from strong partnerships with regulatory bodies and extensive resources for research and development. Their established market presence allows them to leverage advanced technologies to enhance product efficacy and safety. On the other hand, Research Laboratories are positioned as an emerging segment, driven by the pursuit of innovation and exploration of new applications of unnatural amino acids. These laboratories often collaborate with larger companies, facilitating knowledge transfer and the development of cutting-edge methodologies. As the demand for personalized and precision medicine grows, both segments are likely to experience significant growth, albeit driven by different market dynamics. ## Competitive Benchmarking The unnatural amino-acids market is characterized by a dynamic competitive landscape, driven by increasing demand across various sectors, including pharmaceuticals, food and beverages, and nutraceuticals. Key players are actively engaging in strategies that emphasize innovation, regional expansion, and partnerships to enhance their market positioning. For instance, Ajinomoto Co Inc (Japan) has been focusing on expanding its product portfolio through research and development initiatives, which appears to be a critical factor in maintaining its competitive edge. Similarly, Evonik Industries AG (Germany) is leveraging its expertise in biotechnology to develop sustainable production methods, thereby aligning with the growing trend towards environmentally friendly practices.In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. The market structure is moderately fragmented, with several players vying for market share. This fragmentation allows for a diverse range of products and innovations, yet it also intensifies competition among key players. The collective influence of these companies shapes the market dynamics, as they strive to differentiate themselves through unique offerings and operational efficiencies. In October Nutraceutical International Corp (US) announced a strategic partnership with a leading biotechnology firm to enhance its research capabilities in unnatural amino-acids. This collaboration is expected to accelerate the development of novel products, potentially positioning Nutraceutical as a frontrunner in the market. The strategic importance of this partnership lies in its potential to leverage cutting-edge technology and expertise, thereby enhancing product efficacy and consumer appeal. In September Kyowa Hakko Bio Co Ltd (Japan) unveiled a new line of amino-acid-based supplements aimed at the sports nutrition sector. This launch reflects the company's commitment to innovation and its understanding of evolving consumer preferences. By targeting a niche market, Kyowa Hakko is likely to capture a segment of health-conscious consumers, thereby reinforcing its market presence. In August SAB Biotherapeutics Inc (US) secured a $10 million grant from a government agency to advance its research on unnatural amino-acids for therapeutic applications. This funding is pivotal as it not only supports the company's R&D efforts but also underscores the growing recognition of the therapeutic potential of unnatural amino-acids. Such financial backing may enhance SAB's capabilities to innovate and bring new solutions to market. As of November current trends in the unnatural amino-acids market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in production processes. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and efficiency. Looking ahead, competitive differentiation is likely to evolve, shifting from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition may redefine the competitive landscape, compelling companies to invest in R&D and sustainable practices to meet the demands of a more discerning consumer base. ## Recent News & Developments Recent news developments in the US Unnatural Amino Acids Market indicate an increased focus on innovation and collaboration among key players such as Tocris Bioscience, Cayman Chemical, and New England Biolabs. The market has seen significant growth, with notable advancements in applications ranging from pharmaceuticals to agricultural biotechnology, which has highlighted the importance of these compounds in various industry sectors. In July 2023, Evonik Industries announced a partnership with Kyowa Hakko Bio to enhance their production capabilities for amino acid derivatives, reflecting the ongoing consolidation trend in the market. Furthermore, Thermo Fisher Scientific and GenScript have expanded their product portfolios through strategic investments, contributing to a more competitive landscape. On the financial side, companies like Bachem and Ajinomoto reported increased valuations and revenue growth driven by rising demand, which is positively impacting the overall market dynamics. The last couple of years have seen accelerated R&D efforts, particularly in the context of personalized medicine and biopharmaceutical development, reinforcing the critical role of unnatural amino acids in advancing scientific research and commercial applications in the US. ## Report Scope | MARKET SIZE 2024 | 633.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 630.47(USD Million) | | MARKET SIZE 2035 | 605.69(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | -0.4% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Ajinomoto Co Inc (JP), Evonik Industries AG (DE), Fufeng Group Ltd (CN), Kyowa Hakko Bio Co Ltd (JP), Nutraceutical International Corp (US), SAB Biotherapeutics Inc (US), Shaanxi Sciphar Hi-Tech Industry Co Ltd (CN), Sino Lion (CN) | | Segments Covered | Type, Application, End-User | | Key Market Opportunities | Growing demand for personalized nutrition fuels innovation in the unnatural amino-acids market. | | Key Market Dynamics | Rising demand for customized formulations drives innovation in the unnatural amino-acids market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the overall market valuation of the US unnatural amino-acids market in 2024?** A: The overall market valuation was $633.0 Million in 2024. **Q: What is the projected market valuation for the US unnatural amino-acids market in 2035?** A: The projected valuation for 2035 is $605.69 Million. **Q: What is the expected CAGR for the US unnatural amino-acids market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is -0.4%. **Q: Which companies are considered key players in the US unnatural amino-acids market?** A: Key players include Ajinomoto Co Inc, Evonik Industries AG, Fufeng Group Ltd, and others. **Q: What were the valuations for D-Amino Acids & Derivatives in 2024?** A: The valuation for D-Amino Acids & Derivatives was $63.3 Million in 2024. **Q: How did the valuation for Cancer applications in the US unnatural amino-acids market change from 2024 to 2025?** A: The valuation for Cancer applications decreased from $200.0 Million in 2024 to $190.0 Million in 2025. **Q: What is the market valuation for Pharmaceutical & Biotechnological Companies in 2024?** A: The market valuation for Pharmaceutical & Biotechnological Companies was $400.0 Million in 2024. **Q: What were the valuations for Gamma-Amino Butyric Acid (GABA) in 2024?** A: The valuation for Gamma-Amino Butyric Acid (GABA) was $63.3 Million in 2024. **Q: What is the projected valuation for Research Laboratories in 2035?** A: The projected valuation for Research Laboratories in 2035 is $225.69 Million. **Q: How did the valuation for Inflammatory Diseases applications change from 2024 to 2025?** A: The valuation for Inflammatory Diseases applications decreased from $180.0 Million in 2024 to $170.0 Million in 2025. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-unnatural-amino-acids-market-13663*